Loading stock data...

GKB Ophthalmics Limited

BSE: GKB

BSE
69.95 0.57 (0.82%)

Prev Close

69.38

Open Price

70.75

Volume

1,265

Today Low / High

68.16 / 70.75

52 WK Low / High

59 / 101.6

Range

66 - 73

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 69.95, reflecting a change of 0.57 (0.82156%). The expected target range on the BSE is 66 - 73. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

29 Sep 70.75 -1.13%
26 Sep 69.95 -0.81%
25 Sep 70.75 -2.32%
24 Sep 69.00 1.32%
23 Sep 69.51 0.42%
22 Sep 70.37 -1.22%
19 Sep 72.84 -3.40%
18 Sep 70.51 2.79%
17 Sep 74.00 -4.77%
16 Sep 71.60 3.35%
15 Sep 76.60 -6.53%
12 Sep 74.34 -2.29%
11 Sep 73.79 0.26%
10 Sep 70.51 3.08%
09 Sep 73.55 -1.85%
08 Sep 71.22 0.34%
05 Sep 78.80 -7.82%
04 Sep 83.90 -10.87%
03 Sep 76.33 0.31%
02 Sep 78.99 -3.37%
01 Sep 79.80 -1.03%

GKB Ophthalmics Limited Graph

GKB Ophthalmics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for GKB Ophthalmics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 69.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 69.95 70.65 63.58 - 77.71
71.35 57.08 - 85.62
72.05 50.43 - 93.66
Bearish Scenario 69.95 69.25 62.33 - 76.18
68.55 54.84 - 82.26
67.85 47.50 - 88.21

Overview of GKB Ophthalmics Limited

ISIN

INE265D01015

Industry

Medical - Specialties

Vol.Avg

3,289

Market Cap

352,588,571

Last Dividend

0

Official Website

Visit Website

IPO Date

2010-07-07

DCF Diff

120.00

DCF

-43

Financial Ratios Every Investor Needs

Stock Dividend of GKB

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2010-09-21 September 21, 10 1.2 1.2

Stock Rating Details for GKB

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 108.99 Cr 93.79 Cr 15.20 Cr 0.1394 0.00 Cr 1.43 Cr -5.87 Cr -7.04 Cr -13.98 -1.27 Cr -0.0646
2024-03-31 88.25 Cr 62.89 Cr 25.37 Cr 0.2874 0.00 Cr 1.22 Cr -2.32 Cr -2.81 Cr -5.58 1.98 Cr -0.0318
2023-03-31 75.38 Cr 51.29 Cr 24.09 Cr 0.3196 0.00 Cr 1.15 Cr 0.89 Cr -0.17 Cr -0.33 4.54 Cr -0.0022
2022-03-31 70.75 Cr 48.12 Cr 22.62 Cr 0.3198 0.00 Cr 1.07 Cr 2.33 Cr 1.27 Cr 2.53 6.00 Cr 0.0180
2021-03-31 56.44 Cr 40.14 Cr 16.29 Cr 0.2887 0.00 Cr 0.93 Cr -0.79 Cr -0.91 Cr -1.80 3.57 Cr -0.0161

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.02 Cr 125.21 Cr 68.78 Cr 52.0389 Cr 14.50 Cr 11.48 Cr 50.38 Cr 20.94 Cr 0.00 Cr 0.00 Cr 2.06 Cr 62.3862 Cr
2024-03-31 3.23 Cr 114.50 Cr 50.30 Cr 59.7712 Cr 11.49 Cr 8.25 Cr 40.02 Cr 22.12 Cr 0.00 Cr 0.00 Cr 1.83 Cr 46.2270 Cr
2023-03-31 2.36 Cr 112.09 Cr 44.79 Cr 62.6932 Cr 11.22 Cr 8.85 Cr 38.74 Cr 22.98 Cr 4.72 Cr 0.00 Cr 1.89 Cr 41.0896 Cr
2022-03-31 5.89 Cr 110.16 Cr 42.74 Cr 63.0957 Cr 11.75 Cr 5.86 Cr 37.70 Cr 26.06 Cr 0.20 Cr 0.00 Cr -7.95 Cr 38.6934 Cr
2021-03-31 6.01 Cr 106.82 Cr 40.52 Cr 62.6522 Cr 11.97 Cr 5.96 Cr 35.41 Cr 24.24 Cr 0.00 Cr 0.00 Cr 1.76 Cr 38.1159 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -3.4297 Cr 2.5497 Cr 0.6688 Cr -5.5769 Cr -0.2112 Cr 3.0212 Cr -2.1472 Cr -6.7262 Cr 3.0091 Cr 0.0000 Cr -10.3590 Cr
2024-03-31 4.2205 Cr -1.7125 Cr -1.6397 Cr 2.1444 Cr 0.8683 Cr 3.2324 Cr -2.0761 Cr -2.8105 Cr 0.2715 Cr 0.0000 Cr -1.2793 Cr
2023-03-31 -2.7740 Cr 1.4294 Cr -2.1850 Cr -3.9866 Cr -3.5296 Cr 2.3641 Cr -1.2126 Cr 0.1394 Cr -0.5386 Cr -0.0013 Cr -1.0357 Cr
2022-03-31 5.0686 Cr -3.5246 Cr -1.6644 Cr 0.3105 Cr -0.1204 Cr 5.8937 Cr -4.7581 Cr 1.9462 Cr -0.2173 Cr 0.0000 Cr -2.2928 Cr
2021-03-31 6.8556 Cr -16.7751 Cr 2.7672 Cr 0.5232 Cr -7.1521 Cr 6.0141 Cr -6.3324 Cr -0.9075 Cr -3.2030 Cr 0.0000 Cr -4.9928 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 32.31 Cr 21.89 Cr 10.41 Cr 0.3223 0.01 Cr -1.02 Cr -2.02 1.00 Cr -0.0315
2025-03-31 31.02 Cr 22.51 Cr 8.51 Cr 0.2744 -3.65 Cr -3.55 Cr -7.04 -2.50 Cr -0.1143
2024-12-31 25.80 Cr 16.38 Cr 9.43 Cr 0.3654 -1.68 Cr -2.03 Cr -4.03 -0.43 Cr -0.0787
2024-09-30 26.14 Cr 17.29 Cr 8.85 Cr 0.3385 -0.82 Cr -1.22 Cr -2.41 0.22 Cr -0.0465
2024-06-30 26.02 Cr 22.06 Cr 3.96 Cr 0.1522 0.29 Cr -0.25 Cr -0.50 1.47 Cr -0.0098

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 3.02 Cr 0.00 Cr 13.82 Cr 25.49 Cr 50.38 Cr 99.39 Cr 20.94 Cr 125.21 Cr 68.78 Cr
2024-12-31 0.00 Cr 0.00 Cr 17.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -63.04 Cr
2024-09-30 2.21 Cr 15.11 Cr 17.32 Cr 32.02 Cr 43.80 Cr 94.74 Cr 21.42 Cr 121.73 Cr 58.69 Cr
2024-06-30 0.00 Cr 0.00 Cr 17.21 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -64.20 Cr
2024-03-31 3.23 Cr 0.00 Cr 17.21 Cr 0.35 Cr 40.02 Cr 87.48 Cr 22.12 Cr 114.50 Cr 50.30 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 -2.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -1.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -0.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -0.91 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 -1.25 Cr 1.47 Cr 0.00 Cr 0.00 Cr 1.47 Cr 17.22 Cr 15.75 Cr 0.00 Cr 1.47 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Senior Manager of HR & Administration and Non Independent, Executive, Whole Time Director
Mr. Cedric Lobo

Gender: male

Year Born: 1964

Company Secretary & Compliance Officer
Ms. Pooja Bicholkar

Gender: female

Year Born:

Chairman & MD
Mr. Krishna Gopal Gupta

Gender: male

Year Born: 1940

Chief Financial Officer
Mr. Gurudas Sawant

Gender: male

Year Born:

FAQs about GKB Ophthalmics Limited

Who is the CEO of the company?

The CEO is Krishna Gopal Gupta.

What is the current market price of the stock?

The current price is ₹69.95.

What is the 52-week price range?

The range is ₹59-101.6.

What is the market capitalization of the company?

The market capitalization is ₹35.26 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -4.51.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of GKB Ophthalmics Limited (ISIN: INE265D01015) is a leading Medical - Specialties in India. With a market capitalization of ₹35.26 crores and an average daily volume of 3,289 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.